Alterity Therapeutics
ATHE
17 hedge funds and large institutions have $342K invested in Alterity Therapeutics in 2016 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 1 closing their positions.
100% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 1
6% more funds holding
Funds holding: 16 → 17 (+1)
0% more ownership
Funds ownership: 0% → 0% (+0%)
50% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 6
62% less capital invested
Capital invested by funds: $902K → $342K (-$560K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$62.2K |
| 2 |
Morgan Stanley
New York
|
+$15.8K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$8.85K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.67K |
| 5 |
TRCT
Tower Research Capital (TRC)
New York
|
+$1.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GBA
Garrison Bradford & Associates
New York
|
-$70K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$12.7K |
| 3 |
Renaissance Technologies
New York
|
-$7.81K |
| 4 |
Wells Fargo
San Francisco,
California
|
-$2K |
| 5 |
AIM
Advantage Investment Management
Cedar Rapids,
Iowa
|
-$882 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Morgan Stanley
New York
| $198K | +$15.8K | +590 | +5% |
|
|
VKH
2
Virtu KCG Holdings
New York
| $38K | +$8.85K | +331 | +17% |
|
|
3
Citadel Advisors
Miami,
Florida
| $38K | +$62.2K | +2,328 | New |
|
|
4
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $31K | +$2.67K | +100 | +5% |
|
|
5
Renaissance Technologies
New York
| $27K | -$7.81K | -292 | -15% |
|
|
AIM
6
Advantage Investment Management
Cedar Rapids,
Iowa
| $2K | -$882 | -33 | -23% |
|
|
AG
7
Advisor Group
Phoenix,
Arizona
| $2K | – | – | – |
|
|
8
UBS Group
Zurich,
Switzerland
| $1K | -$12.7K | -475 | -92% |
|
|
9
Wells Fargo
San Francisco,
California
| $1K | -$2K | -75 | -47% |
|
10
Bank of America
Charlotte,
North Carolina
| $1K | -$214 | -8 | -15% |
|
11
Group One Trading
Chicago,
Illinois
| $1K | – | – | – |
|
|
MFS
12
MSI Financial Services
Springfield,
Massachusetts
| $1K | – | – | – |
|
|
TRCT
13
Tower Research Capital (TRC)
New York
| $1K | +$1.36K | +51 | New |
|
|
GBA
14
Garrison Bradford & Associates
New York
| – | -$70K | -1,555 | Closed |
|
|
TWA
15
TCI Wealth Advisors
Tucson,
Arizona
| – | -$214 | -8 | -80% |
|
ATHE Hedge Fund Activity: Q4 2016 in Review
17 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Alterity Therapeutics (ATHE) for Q4 2016, worth a combined $342K — down 62% from $902K a quarter earlier.
Buyers outnumbered sellers: 2 funds opened new ATHE positions and 1 closed out — a net gain of 1 holder — while 3 added to existing stakes and 6 trimmed.
The largest buyer was Citadel Advisors, opening a new position worth an estimated $62.2K. The largest seller was Garrison Bradford & Associates, exiting entirely with an estimated $70K sold.
- 17 institutional investors held Alterity Therapeutics (ATHE) as of Q4 2016, up from 16 in Q3 2016.
- Funds reported $342K of Alterity Therapeutics stock for Q4 2016, down 62% quarter-over-quarter.
- 2 funds opened new Alterity Therapeutics positions in Q4 2016 and 1 closed out, a net change of +1 holder.
- The largest Alterity Therapeutics buyer in Q4 2016 was Citadel Advisors, an estimated $62.2K added.
- The largest Alterity Therapeutics seller in Q4 2016 was Garrison Bradford & Associates, an estimated $70K sold.
Based on aggregated 13F filings for Q4 2016.